ROQUIN基因家族的罕见突变在罕见免疫炎症及自身免疫疾病发生发展中的作用

结题报告
项目介绍
AI项目解读

基本信息

  • 批准号:
    81873879
  • 项目类别:
    面上项目
  • 资助金额:
    65.0万
  • 负责人:
  • 依托单位:
  • 学科分类:
    H1107.自身免疫性疾病
  • 结题年份:
    2022
  • 批准年份:
    2018
  • 项目状态:
    已结题
  • 起止时间:
    2019-01-01 至2022-12-31

项目摘要

Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially life threatening systemic autoinflammatory syndrome that is either associated with genetic abnormalities resulting in defective natural killer (NK)/cytotoxic T-cell function or acquired in the setting of conditions, such as infections, autoimmunity, or malignancy. Its actual prevalence may be higher than reported as it tends to be underdiagnosed due to heterogeneity in symptoms, particularly when in the context of associated underlying conditions. Current treatment involves prompt therapy with immunosuppression combined with chemotherapy. However, half of patients with HLH either fail to respond adequately or relapse before hematopoietic cell transplantation indicating a clear need for new treatments..Systemic lupus erythematosus (SLE) is considered the prototypical systemic autoimmune disease and its incidence is particularly high in China. SLE has a strong genetic component. Disease manifestations of SLE are highly heterogeneous. Dissecting the heterogeneity in pathogenesis and stratification of patients according to affected pathways will illuminate targeted therapies and improve the success of clinical trials. There is an increasing number of genes found to cause monogenic human SLE. Nevertheless SLE mostly follows complex, non-Mendelian patterns of inheritance. It is unclear whether it is the combination of a few rare, potent variants or tens to hundreds of common, mild variants that contribute to SLE; it is reasonable to expect that it will be a combination of both. No matter what the genetics are, the identification of any causative allele will be extremely useful to dissect disease mechanisms and identify superior biomarkers and pathway targeted therapies..We have now sequenced the whole exomes or genomes of patients with immune disorders and discovered 27 novel and rare missense allelic variants in the genes encoding the ROQUIN family fambers RC3H1 (11 variants) and RC3H2 (8 variants) and in the ZC3H12A gene encoding the ROQUIN-interacting protein REGNASE-1 (8 variants) in patients presenting with lupus or HLH. These mutations are found in different domains of the proteins. A mutation in mouse Roquin was sufficient to cause a lupus-like disease associated with high cytokine production, and can also cause a tumour closely resembling angioimmunoblastic T cell lymphoma. In both of these conditions, follicular helper T cells and cytotoxic T cells are dysregulated. To date, there are no reports of mutations in ROQUIN and its immediate partner proteins causing human immune diseases..In this proposal, we will investigate whether variants in the ROQUIN family can be identified in the Chinese population, test disease causation of variants identified so far, and identify the mechanisms by which these variants cause immune disease. This will be achieved through the generation of cell and mouse lines bearing some of these ROQUIN family variants using CRISPR/Cas9..Overall hypothesis: Novel or rare mutations in the ROQUIN family cause systemic autoimmune and autoinflammatory syndromes through aberrant stabilization of mRNA transcripts encoding pro-inflammatory cytokines and enhance NF-kB signaling. Patients with mutations in these genes may respond to cytokine-targeted therapies including JAK inhibitors.
嗜血细胞性淋巴组织细胞增生症(HLH)是一种罕见的,危及生命的全身性自身炎症综合征。系统性红斑狼疮(SLE)是系统性自身免疫疾病,发病率高,与遗传相关并高度异质。目前尚不清楚一些罕见的变异是否导致这两种疾病。鉴定致病等位基因对于分析疾病机制和精准治疗至关重要。通过测序狼疮或HLH患者的外显子组或基因组,我们在编码ROQUIN家族3个基因中发现了27个新的罕见错义等位基因突变。小鼠Roquin突变会引起狼疮样疾病或T细胞淋巴瘤。迄今还没有关于引起人类免疫性疾病的ROQUIN及其伴侣蛋白突变的报道。我们认为ROQUIN家族中新的罕见突变通过编码促炎细胞因子的mRNA转录物并增强NF-kB信号传导引起疾病。这些患者可能会对包括JAK抑制剂在内的靶向治疗产生应答。我们将调查中国人群中的ROQUIN家族中突变并通过使用CRISPR / Cas9产生带有ROQUIN家族突变的细胞和小鼠来研究发病机制。

结项摘要

嗜血细胞性淋巴组织细胞增生症(HLH)是一种罕见的全身性自身炎症综合征。通过对HLH患者的外显子组测序,我们发现一例患者携带ROQUIN-1基因罕见无义突变R688*,该突变使ROQUIN-1功能缺陷,ROQUIN-1基因缺陷的狼疮小鼠模型表现出明显的高细胞因子血症,免疫失调,同时ROQUIN-1中R688*无义突变导致其与P小体共定位受损,基因ICOS的mRNA降解过程被突变型ROQUIN-1所阻断。此外我们在HLH患者中也发现了多个Regnase-1的罕见突变位点,双荧光报告预实验提示Regnase-1突变位点P346H,V191M和R293H在不同程度上影响NFkB通路。我们也在HLH患者中发现了SOCS1的罕见突变T53A,该突变影响其蛋白的稳定性,同时,该突变促进IFN-a和IFN-γ诱导的JAKS-STAT1通路的激活。这些突变的发现及对其机制的研究有助于找到治疗疾病的新的靶点通路。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TLR7 gain-of-function genetic variation causes human lupus.
TLR7 功能获得性遗传变异导致人类狼疮
  • DOI:
    10.1038/s41586-022-04642-z
  • 发表时间:
    2022-05
  • 期刊:
    Nature
  • 影响因子:
    64.8
  • 作者:
  • 通讯作者:
P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance.
狼疮患者的 P2RY8 变异揭示了受体在免疫耐受中的作用。
  • DOI:
    10.1084/jem.20211004
  • 发表时间:
    2022-01-03
  • 期刊:
    The Journal of experimental medicine
  • 影响因子:
    --
  • 作者:
    He Y;Gallman AE;Xie C;Shen Q;Ma J;Wolfreys FD;Sandy M;Arsov T;Wu X;Qin Y;Zhang P;Jiang S;Stanley M;Wu P;Tan J;Ding H;Xue H;Chen W;Xu J;Criswell LA;Nititham J;Adamski M;Kitching AR;Cook MC;Cao L;Shen N;Cyster JG;Vinuesa CG
  • 通讯作者:
    Vinuesa CG
A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation
一种人类免疫失调综合征,其特征是伴有纯合无义 Roquin-1 突变的严重过度炎症
  • DOI:
    10.1038/s41467-019-12704-6
  • 发表时间:
    2019-10-21
  • 期刊:
    NATURE COMMUNICATIONS
  • 影响因子:
    16.6
  • 作者:
    Tavernier, S. J.;Athanasopoulos, V.;Haerynck, F.
  • 通讯作者:
    Haerynck, F.

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi || "--"}}
  • 发表时间:
    {{ item.publish_year || "--" }}
  • 期刊:
    {{ item.journal_name }}
  • 影响因子:
    {{ item.factor || "--"}}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ patent.updateTime }}

其他文献

Regnase-1 and Roquin regulate common inflammation-related mRNAs in translation-dependent and independent manners.
Regnase-1 和 Roquin 以翻译依赖和独立的方式调节常见的炎症相关 mRNA。
  • DOI:
    --
  • 发表时间:
    2015
  • 期刊:
    Cell
  • 影响因子:
    64.5
  • 作者:
    Takashi Mino;Yasuhiro Murakawa;Akira Fukao;Alexis Vandenbon;Hans-Hermann Wessels;Daisuke Ori;Takuya Uehata;Sarang Tartey;Shizuo Akira;Yutaka Suzuki;Carola G. Vinuesa;Uwe Ohler;Daron M. Standley;Markus Landthaler;Toshinobu Fujiwara;Osamu Tak
  • 通讯作者:
    Osamu Tak
Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens
特殊 B 细胞对多糖封装病原体反应的临床意义
  • DOI:
    --
  • 发表时间:
    2001
  • 期刊:
    Postgraduate medical journal
  • 影响因子:
    5.1
  • 作者:
    Carola G. Vinuesa;C. D. Lucas;Matthew C. Cook
  • 通讯作者:
    Matthew C. Cook

其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi || "--" }}
  • 发表时间:
    {{ item.publish_year || "--"}}
  • 期刊:
    {{ item.journal_name }}
  • 影响因子:
    {{ item.factor || "--" }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}
empty
内容获取失败,请点击重试
重试联系客服
title开始分析
查看分析示例
此项目为已结题,我已根据课题信息分析并撰写以下内容,帮您拓宽课题思路:

AI项目思路

AI技术路线图

相似国自然基金

{{ item.name }}
  • 批准号:
    {{ item.ratify_no }}
  • 批准年份:
    {{ item.approval_year }}
  • 资助金额:
    {{ item.support_num }}
  • 项目类别:
    {{ item.project_type }}

相似海外基金

{{ item.name }}
{{ item.translate_name }}
  • 批准号:
    {{ item.ratify_no }}
  • 财政年份:
    {{ item.approval_year }}
  • 资助金额:
    {{ item.support_num }}
  • 项目类别:
    {{ item.project_type }}
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了

AI项目解读示例

课题项目:调控A型流感病毒诱导IFN-β表达的机制研究

AI项目摘要:

本研究聚焦于TRIM2蛋白在A型流感病毒诱导的IFN-β表达中的调控机制。A型流感病毒是全球性健康问题,其感染可导致严重的呼吸道疾病。IFN-β作为关键的抗病毒因子,其表达水平对抗病毒防御至关重要。然而,TRIM2如何调控IFN-β的表达尚未明确。本研究假设TRIM2通过与病毒RNA或宿主因子相互作用,影响IFN-β的产生。我们将采用分子生物学、细胞生物学和免疫学方法,探索TRIM2与A型流感病毒诱导IFN-β表达的关系。预期结果将揭示TRIM2在抗病毒免疫反应中的作用,为开发新的抗病毒策略提供理论基础。该研究对理解宿主抗病毒机制具有重要科学意义,并可能对临床治疗流感病毒感染提供新的视角。

AI项目思路:

科学问题:TRIM2如何调控A型流感病毒诱导的IFN-β表达?
前期研究:已有研究表明TRIM2参与抗病毒反应,但其具体机制尚不明确。
研究创新点:本研究将深入探讨TRIM2在IFN-β表达中的直接作用机制。
技术路线:包括病毒学、分子生物学、细胞培养和免疫检测技术。
关键技术:TRIM2与病毒RNA的相互作用分析,IFN-β启动子活性检测。
实验模型:使用A型流感病毒感染的细胞模型进行研究。

AI技术路线图

        graph TD
          A[研究起始] --> B[文献回顾与假设提出]
          B --> C[实验设计与方法学准备]
          C --> D[A型流感病毒感染模型建立]
          D --> E[TRIM2与病毒RNA相互作用分析]
          E --> F[TRIM2对IFN-β启动子活性的影响]
          F --> G[IFN-β表达水平测定]
          G --> H[TRIM2功能丧失与获得研究]
          H --> I[数据收集与分析]
          I --> J[结果解释与科学验证]
          J --> K[研究结论与未来方向]
          K --> L[研究结束]
      
关闭
close
客服二维码